CLINICAL FELLOW
M_IHPS (Health Policy Studies)
Dr. Naveen Reddy is a Neurologist and implementation scientist investigating the impact of advanced medical technologies on the delivery and practice of medicine. Dr. Reddy has developed policies to sustainably integrate newly approved medical technologies (anti-amyloid therapies and Alzheimer's blood based biomarkers) into the Veteran’s Health Administration. He is specifically interested in the emerging pharmaceutical spaces attempting to diagnose and treat neurodegenerative diseases and headache disorders.
Publications
FDA approval of benzgalantamine exposes flaws in the 505(b)(2) pathway for innovations on existing drugs.
BMJ evidence-based medicine
Implementation of Lecanemab for Alzheimer's Disease Within the Veterans Health Administration: Facilitators and Barriers.
Journal of the American Geriatrics Society
Redefining disease in the age of blood-based biomarkers.
Frontiers in sociology
New Drugs Could Help Alzheimer’s Patients Live Longer: Is the Health Care System Ready?
San Diego Tribune
A Critique of Commodified Healthcare
New Politics
Functional Diseases, Functional Cures
Neurology
Spiro Essay Contest: The Modern Doctor-Patient Relationship
Connecticut medicine
Effect of Immunotherapy and Stereotactic Radiosurgery on Cognitive Function and Quality of Life In Survivors of Metastatic Brain Malignancies
Journal of Clinical Oncology
Journal of Clinical Oncology
Effect of immunotherapy and stereotactic radiosurgery on cognitive function and quality of life in long term survivors of metastatic brain malignancies